Citations

Mayo Clinic

Showing 10 of 108551 citations.

An Integrated Approach Including CRISPR/Cas9-Mediated Nanopore Sequencing, Mate Pair Sequencing, and Cytogenomic Methods to Characterize Complex Structural Rearrangements in Acute Myeloid Leukemia
Phan, Michael , Morsberger, Laura, Hoppman, Nicole L., Pearce, Kathryn E., Smith, Kirstin, Phan, Brian, Zou, Ying , Zou, Ying S , Gomes, Maria A., Stinnett, Victoria L , Jiang, Liqun

Biomedicines | March 7, 2024 | Volume: 12 | Issue: 3 | Pages: 598

10.3390/biomedicines12030598 | PMID 38540211 Get It

Complex structural chromosome abnormalities such as chromoanagenesis have been reported in acute myeloid leukemia (AML). They are usually not well characterized by conventional genetic methods, and the characterization of chromoanagenesis structural abnormalities from short-read sequencing still presents challenges. Here, we characterized complex structural abnormalities involving chromosomes 2, 3, and 7 in an AML patient using an integrated approach including CRISPR/Cas9-mediated nanopore sequencing, mate pair sequencing (MPseq), and SNP microarray analysis along with cytogenetic methods. SNP microarray analysis revealed chromoanagenesis involving chromosomes 3 and 7, and a pseudotricentric chromosome 7 was revealed by cytogenetic methods. MPseq revealed 138 structural variants (SVs) as putative junctions of complex rearrangements involving chromosomes 2, 3, and 7, which led to 16 novel gene fusions and 33 truncated genes. Thirty CRISPR RNA (crRNA) sequences were designed to map 29 SVs, of which 27 (93.1%) were on-target based on CRISPR/Cas9 crRNA nanopore sequencing. In addition to simple SVs, complex SVs involving over two breakpoints were also revealed. Twenty-one SVs (77.8% of the on-target SVs) were also revealed by MPseq with shared SV breakpoints. Approximately three-quarters of breakpoints were located within genes, especially intronic regions, and one-quarter of breakpoints were intergenic. Alu and LINE repeat elements were frequent among breakpoints. Amplification of the chromosome 7 centromere was also detected by nanopore sequencing. Given the high amplification of the chromosome 7 centromere, extra chromosome 7 centromere sequences (tricentric), and more gains than losses of genomic material, chromoanasynthesis and chromothripsis may be responsible for forming this highly complex structural abnormality. We showed this combination approach’s value in characterizing complex structural abnormalities for clinical and research applications. Characterization of these complex structural chromosome abnormalities not only will help understand the molecular mechanisms responsible for the process of chromoanagenesis, but also may identify specific molecular targets and their impact on therapy and overall survival.
Aspergillus myelitis : Breaking the mold to make a diagnosis
Flanagan, Eoin P.

Multiple Sclerosis Journal | March 7, 2024 | Volume: 30 | Issue: 6 | Pages: 758-759

10.1177/13524585241237385 | PMID 38450617 Get It

Individualized prediction of critical illness in older adults: Validation of an elders risk assessment model
Boswell, Christopher L. , Hanson, Andrew C. , Barwise, Amelia , Herasevich, Svetlana , Minteer, Sarah A. , Barwise, Amelia K , Dong, Yue , Gajic, Ognjen

Journal of the American Geriatrics Society | March 7, 2024 | Volume: 72 | Issue: 6 | Pages: 1839-1846

10.1111/jgs.18861 | PMID 38450712 Get It

Abstract Background The electronic health record (EHR) presents new opportunities for the timely identification of patients at high risk of critical illness and the implementation of preventive strategies. This study aims to externally validate an EHR‐based Elders Risk Assessment (ERA) score to identify older patients at high risk of future critical illness during a primary care visit. Methods This historical cohort study included patients aged ≥65 years who had primary care visits at Mayo Clinic Rochester, MN, between July 2019 and December 2021. The ERA score at the time of the primary care visit was used to predict critical illness, defined as death or ICU admission within 1 year of the visit. Results A total of 12,885 patients were included in the analysis. The median age at the time of the primary care visit was 75 years, with 44.6% being male. 93.7% of participants were White, and 64.2% were married. The median (25th, 75th percentile) ERA score was 4 (0, 9). 11.3% of study participants were admitted to the ICU or died within 1 year of the visit. The ERA score predicted critical illness within 1 year of a primary care visit with an area under the receiver operating characteristic curve of 0.84 (95% CI 0.83–0.85), which indicates good discrimination. An ERA score of 9 was identified as optimal for implementing and testing potential preventive strategies, with the odds ratio of having the primary outcome in patients with ERA score ≥9 being 11.33 (95%CI 9.98–12.87). Conclusions This simple EHR‐based risk assessment model can predict critical illness within 1 year of primary care visits in older patients. The findings of this study can serve as a basis for testing and implementation of preventive strategies to promote the well‐being of older adults at risk of critical illness and its consequences.
Racial and Ethnic Disparities in Otolaryngology Office Visit and Tympanostomy Tube Placement in Children with Otitis Media
Shi, Yu , Heien, Herbert C., Orvidas, Laura J. , Sangaralingham, Lindsey R. , Halbauer, Moira, Phelan, Sean, Warner, David O. , Phelan, Sean M.

The Laryngoscope | March 7, 2024 | Volume: 134 | Issue: 8 | Pages: 3846-3852

10.1002/lary.31380 | PMID 38450789 Get It

ObjectivesRacial disparities are pervasive in access to pediatric surgery. The goal of this study was to test the hypotheses that, compared with White children, non‐White and Hispanic children: (1) were less likely to attend evaluations by otolaryngologists after a diagnosis of otitis media (OM) eligible for surgical referral, and (2) these children were less likely to receive tympanostomy tube (TT) after surgical consultation.MethodsThe OptumLabs Data Warehouse is a de‐identified claims database of privately insured enrollees. Guidelines on the management of OMs suggest that children should be evaluated for surgery if they have recurrent acute OM or chronic OM with effusion. A cohort of children who were diagnosed with OM were constructed. For Hypothesis 1, the primary outcome was otolaryngology office visit within 6 months of a diagnosis of recurrent or chronic OM. For Hypothesis 2, the outcome was TT placement within 6 months following the otolaryngology office visit. Cox regression models were used to determine the relationship between race/ethnicity and the primary outcomes.ResultsAmong 187,776 children with OMs, 72,774 (38.8%) had otolaryngology visits. In a multivariate Cox model, the hazard ratios of attending otolaryngology visit for Black, Hispanic, and Asian children were 0.93 (95% CI,0.90, 0.96), 0.86 (0.83, 0.88), and 0.74 (0.71, 0.77), compared with White children. Among the children evaluated by otolaryngologists, 46,554 (63.97%) received TT. Black, Hispanic, and Asian children with recurrent acute OM had lower likelihood of receiving TT.ConclusionsRacial disparities in attending otolaryngology office visit contributed to the disparities in receiving TT.Quality of EvidenceLevel 3 Laryngoscope, 134:3846–3852, 2024
The Functional Implications of Transanal Irrigation: Insights from Pathophysiology and Clinical Studies of Neurogenic Bowel Dysfunction
Rodriguez, Gianna M. , Thảo, Mai Phương, McArthur, Mackenzie, Camilleri, Michael , Kirshblum, Steven

Journal of Clinical Medicine | March 7, 2024 | Volume: 13 | Issue: 6 | Pages: 1527

10.3390/jcm13061527 | PMID 38541753 Get It

Defecation function is negatively impacted in patients with neurogenic bowel dysfunction (NBD), who require effective bowel care for stool evacuation. NBD comprises fecal incontinence and/or constipation, which can reduce the quality of life and dignity. Transanal irrigation (TAI) is recommended by several clinical guidelines as the second-line treatment after conservative treatment and before surgical options are considered. As the only class in the second-line treatment with an established safety and efficacy profile, the mechanism of action of TAI has not fully been elucidated when administered through a rectal catheter with a balloon. This review examines the current understanding regarding the mechanism of action of TAI, with a focus on the pathophysiology of neurogenic bowel and irregular defecation. By understanding the functional implications of TAI, clinicians may be better able to integrate this modality into bowel care programs, especially for patients with NBD who have significant constipation due to delayed colonic motility and impaired stool emptying with loss of voluntary control of defecation, and those who are unresponsive to conservative treatment, including enemas.
Reply: Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial
Trost, Landon

Journal of Urology | March 6, 2024 | Volume: 211 | Issue: 5 | Pages: 710-712

10.1097/ju.0000000000003896 | PMID 38447151 Get It

Automated whole slide morphometry of sural nerve biopsy using machine learning
Ono, Daisuke , Kawai, Honami , Kuwahara, Hiroya , Yokota, Takanori

Neuropathology and Applied Neurobiology | March 6, 2024 | Volume: 50 | Issue: 2 | Pages: No page available

10.1111/nan.12967 | PMID 38448224 Get It

Abstract Aim The morphometry of sural nerve biopsies, such as fibre diameter and myelin thickness, helps us understand the underlying mechanism of peripheral neuropathies. However, in current clinical practice, only a portion of the specimen is measured manually because of its labour‐intensive nature. In this study, we aimed to develop a machine learning‐based application that inputs a whole slide image (WSI) of the biopsied sural nerve and automatically performs morphometric analyses. Methods Our application consists of three supervised learning models: (1) nerve fascicle instance segmentation, (2) myelinated fibre detection and (3) myelin sheath segmentation. We fine‐tuned these models using 86 toluidine blue‐stained slides from various neuropathies and developed an open‐source Python library. Results Performance evaluation showed (1) a mask average precision (AP) of 0.861 for fascicle segmentation, (2) box AP of 0.711 for fibre detection and (3) a mean intersection over union (mIoU) of 0.817 for myelin segmentation. Our software identified 323,298 nerve fibres and 782 fascicles in 70 WSIs. Small and large fibre populations were objectively determined based on clustering analysis. The demyelination group had large fibres with thinner myelin sheaths and higher g‐ratios than the vasculitis group. The slope of the regression line from the scatter plots of the diameters and g‐ratios was higher in the demyelination group than in the vasculitis group. Conclusion We developed an application that performs whole slide morphometry of human biopsy samples. Our open‐source software can be used by clinicians and pathologists without specific machine learning skills, which we expect will facilitate data‐driven analysis of sural nerve biopsies for a more detailed understanding of these diseases.
Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet components
Wheeler, Allison P. , Snyder, Edward L. , Refaai, Majed A. , Cohn, Claudia S. , Poisson, Jessica , Fontaine, Magali J. , Sehl, Mary E. , Uhl, Lynne , Fenelus, Maly , Coyle, Thomas, Becker, Joanne , Jeng, Michael , Young, Pampee P. , OʼBrien, Jennifer , Schiller, Gary J. , Roback, John D. , Malynn, Elizabeth, Jackups, Ronald , Avecilla, Scott T. , Bentow, Stanley, Varrone, Jeanne, Fontaine, Magali , Fenelus, Maly , Jeng, Michael , Spencer, Bryan R , O'Brien, Jennifer J, Roback, John D , Avecilla, Scott T , Benjamin, Richard J , Cohn, Claudia S , Wheeler, Allison P , Nooka, Ajay K. , Spinella, Philip C. , Liles, Darla , Gehrie, Eric A , Spencer, Bryan R. , Johnson, Andrew, Liu, Kathy , Corash, Laurence M

Blood Advances | March 6, 2024 | Volume: 8 | Issue: 9 | Pages: 2290-2299

10.1182/bloodadvances.2023012425 | PMID 38447116 Get It

Abstract Patients treated with antineoplastic therapy often develop thrombocytopenia requiring platelet transfusion, which has potential to exacerbate pulmonary injury. This study tested the hypothesis that amotosalen-UVA pathogen–reduced platelet components (PRPCs) do not potentiate pulmonary dysfunction compared with conventional platelet components (CPCs). A prospective, multicenter, open-label, sequential cohort study evaluated the incidence of treatment-emergent assisted mechanical ventilation initiated for pulmonary dysfunction (TEAMV-PD). The first cohort received CPC. After the CPC cohort, each site enrolled a second cohort transfused with PRPC. Other outcomes included clinically significant pulmonary adverse events (CSPAE) and the incidence of treatment-emergent acute respiratory distress syndrome (TEARDS) diagnosed by blinded expert adjudication. The incidence of TEAMV-PD in all patients (1068 PRPC and 1223 CPC) was less for PRPC (1.7 %) than CPC (3.1%) with a treatment difference of –1.5% (95% confidence interval [CI], –2.7 to –0.2). In patients requiring ≥2 PCs, the incidence of TEAMV-PD was reduced for PRPC recipients compared with CPC recipients (treatment difference, –2.4%; 95% CI, –4.2 to –0.6). CSPAE increased with increasing PC exposure but were not significantly different between the cohorts. For patients receiving ≥2 platelet transfusions, TEARDS occurred in 1.3% PRPC and 2.6% CPC recipients (P = .086). Bayesian analysis demonstrated PRPC may be superior in reducing TEAMV-PD and TEARDS for platelet transfusion recipients compared with CPC recipients, with 99.2% and 88.8% probability, respectively. In this study, PRPC compared with CPC demonstrated high probability of reduced severe pulmonary injury requiring assisted mechanical ventilation in patients with hematology disorders dependent on platelet transfusion. This trial was registered at www.ClinicalTrials.gov as #NCT02549222.
A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma
Schuetze, Scott M. , Heise, Rachel S. , Ganjoo, Kristen N. , Davis, Elizabeth J. , George, Suzanne , Burgess, Melissa , Choy, Edwin , Shepard, Dale R. , Tinoco, Gabriel , Kelly, Ciara M. , Attia, Steven , Deshpande, Hari A. , Riedel, Richard F. , Kozlowski, Erin , Astbury, Caroline , Ballman, Karla V. , Schuetze, Scott M , Heise, Rachel , Ganjoo, Kristen N , Davis, Elizabeth J , George, Suzanne , Burgess, Melissa A , Choy, Edwin , Shepard, Dale R , Tinoco, Gabriel , Hirbe, Angela C , Kelly, Ciara M , Attia, Steven , Deshpande, Hari A , Schwartz, Gary K , Siontis, Brittany L , Riedel, Richard F , von Mehren, Margaret , Kozlowski, Erin , Chen, Helen X , Astbury, Caroline , Rubin, Brian P. , Ballman, Karla , Hirbe, Angela C. , Schwartz, Gary K. , Siontis, Brittany L. , Mehren, Margaret von

Clinical Cancer Research | March 6, 2024 | Volume: 30 | Issue: 20 | Pages: 4584-4592

10.1158/1078-0432.ccr-23-3817 | PMID 38446990 Get It

Abstract Purpose: Epithelioid hemangioendothelioma (EHE) is a rare vascular cancer with pathogenic TAZ–CAMTA1 (calmodulinbinding transcription activator 1) operating as an oncogenic driver through activation of the MAPK pathway. Trametinib is an inhibitor of MEK, a critical kinase in the MAPK pathway. We sought to evaluate the effect of trametinib in patients with EHE. Patients and Methods: A phase 2 trial of trametinib was conducted in patients with locally advanced or metastatic EHE. Eligibility requirements included evidence of tumor progression or presence of EHE-related pain requiring opiates for management before enrollment. The primary endpoint was objective response rate (ORR) as per RECIST1.1 in cases with TAZ– CAMTA1 confirmed by fusion-FISH. Secondary objectives were to estimate ORR for all patients, median progression-free survival (PFS), 2-year overall survival (OS) rate, patient safety, and change in patient-reported global health and pain scores per PROMIS questionnaires. Results: 44 patients enrolled and 42 started trametinib. TAZ– CAMTA1 was detected in 27 tumor samples. TheORRwas 3.7%[95% confidence interval (CI), 0.094–19.0], median PFS was 10.4 months (95%CI, 7.1–NA), and 2-year OS rate was 33.3%(95%CI, 19.1–58.2) in the target population. Median pain intensity and interference scores improved significantly after 4 weeks of trametinib in patients using opiates. Common adverse events related to trametinib were rash, fatigue, nausea/vomiting, diarrhea/constipation, alopecia, and edema; one grade 5 ARDS/pneumonitis was related to trametinib. Conclusions: Trametinib was associated with reduction in EHE-related pain and median PFS of more than 6 months, providing palliative benefit in patients with advanced EHE, but the trial did not meet the ORR goal. See related commentary by Van Tine and Haarberg, p. 4552
Erythematous Plaque Studded With Papules and Pustules in an Immunocompetent Patient
Shahin, Ahmad , Idriss, Munir H., Lehman, Julia S. , Shahin, Ahmad B , Lehman, Julia S

JAMA Dermatology | March 6, 2024 | Volume: 160 | Issue: 5 | Pages: 567

10.1001/jamadermatol.2023.5597 | PMID 38446440 Get It

A male patient was evaluated by the dermatology inpatient consult service after a 5-week history of a skin lesion on the right anterior thigh with intermittent itching and mild tenderness to palpation. What is your diagnosis?